ROMEGA® PRENATAL
ROMEGA® PRENATAL is is tailored for individuals seeking extra support for inflammation, including those with PCOS and Endometriosis. It’s also recommended for those undergoing IVF or aiming to enhance egg quality.
Phospholipids containing the omega-3 fatty acid docosahexaenoic acid (DHA) and Specialized Pro-resolving Mediators (SPMs) support fertility by improving the structural integrity and function of reproductive cells, mitigating inflammation, and enhancing hormonal balance. DHA is crucial for oocyte quality, sperm maturation, and embryo implantation, while SPMs, derived from omega-3s, resolve inflammation that can hinder reproductive success.
ROMEGA® PRENATAL is a unique source of Omega-3 derived from Arctic herring caviar, rich in DHA, EPA, and choline bound to phospholipids (Lyso–PC–DHA). This form facilitates active uptake in the brain, retina, and placenta, making these nutrients essential for the fetal development of the brain and vision, and thus ideal for pregnant and breastfeeding women.
Its natural abundance in Specialized Pro-resolving Mediators (SPMs)—lipid compounds that actively resolve inflammation—helps regulate immune responses during pregnancy and supports the physical and mental well-being of the mother.
DHA in breast milk predominantly exists in phospholipid form. Therefore, it is a major advantage for the mother to receive DHA in the cell-membrane-friendly form preferred by nature, which ROMEGA® PRENATAL provides through its supplement.
The high DHA content of ROMEGA® PRENATAL effectively meets the increased needs of expecting mothers—exceeding 250–300 mg of DHA per day during pregnancy and lactation, as recommended by the European Food Safety Authority (EFSA). ROMega® PRENATAL provides 340 mg of DHA per 2 small soft gel capsules, in a bioavailable form for immediate uptake via the placenta and the blood-brain barrier (BBB).